| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in TARS over the last quarter tilts toward selling: insiders offloaded a net 29,850 shares worth roughly $1.8M.
TARS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.0K | $55.09M | - | |
| Dir | 108.7K | $6.98M | - | |
| COO | 79.2K | $5.08M | - | |
| Other | 56.8K | $3.65M | - | |
| Other | 24.3K | $1.56M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2023 | Neervannan Seshadri | Chief Operating Officer | Sell | 1,141 | $12.55 | $14,324.14 | -0.7% | +51.2% | +176.9% | |
| Mar 20, 2023 | Whitfield Dianne C. | Chief Human Resources Officer | Sell | 649 | $12.94 | $8,395.61 | -2.6% | +46.1% | +141.5% | |
| Mar 20, 2023 | Wahl Bryan | General Counsel | Sell | 696 | $12.94 | $9,003.69 | -1.9% | +46.1% | +141.5% | |
| Mar 20, 2023 | Neervannan Seshadri | Chief Operating Officer | Sell | 740 | $12.94 | $9,572.60 | -0.7% | +46.1% | +141.5% | |
| Mar 20, 2023 | Trevejo Jose M. | Chief Medical Officer | Sell | 1,034 | $12.94 | $13,376.42 | -6.2% | +46.1% | +141.5% | |
| Mar 20, 2023 | Greenstein Leonard M. | Chief Financial Officer | Sell | 649 | $12.94 | $8,395.61 | -1.0% | +46.1% | +141.5% | |
| Mar 20, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 1,536 | $12.96 | $19,901.61 | -6.5% | +46.1% | +141.5% | |
| Mar 20, 2023 | Mottiwala Aziz51 | Chief Commercial Officer | Sell | 697 | $12.94 | $9,016.30 | -0.6% | +46.1% | +141.5% | |
| Mar 20, 2023 | Holdbrook Mark J. | V.p., Clinical Affairs | Sell | 386 | $12.94 | $4,993.42 | -5.5% | +46.1% | +141.5% | |
| Mar 16, 2023 | Wahl Bryan | General Counsel | Sale+OE | 337 | $13.43 | $4,525.91 | -1.8% | +38.5% | +135.3% |